# FDA Inspection 1146564 - Octapharma Plasma, Inc. - July 01, 2021

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/bc786a6e-69ff-459b-b52c-cacff78bccc2
Source feed: FDA_Inspections

> FDA Inspection 1146564 for Octapharma Plasma, Inc. on July 01, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1146564
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2021-07-01
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1146564 - 2021-07-01](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/52abeba2-1dd9-4eb0-b226-a0dd0d0f5903)
- [FDA Inspection 1044211 - 2018-02-01](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/e314da94-5953-46ee-8633-0010ffc3f90b)
- [FDA Inspection 976264 - 2016-06-02](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/a01729d2-76f7-45d3-98ff-58b688e25cc1)
- [FDA Inspection 898141 - 2014-09-11](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/a9670ad2-1302-480d-85fd-bc559498d433)
- [FDA Inspection 766939 - 2012-02-03](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/213e6b58-aaa1-4aa4-b079-930210a91f80)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/ad7e7be8-5527-4256-aa17-c4d55cb680fe

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d